Recent

% | $
Quotes you view appear here for quick access.

Velti Halka Acık Limited Şirket Message Board

seekingprofits247 50 posts  |  Last Activity: Jul 27, 2015 2:41 PM Member since: Jan 31, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    If it takes this long to get 5 people

    by buy_n_hold_2001 Jul 27, 2015 1:54 PM
    seekingprofits247 seekingprofits247 Jul 27, 2015 2:41 PM Flag

    They need more sites and they need them in locations that are known to have high rates of motor vehicle accidents. Nationally, DC/Baltimore are at the top of the list, yet neither University of Maryland or Johns Hopkins are on the list.

  • seekingprofits247 seekingprofits247 Jul 27, 2015 2:36 PM Flag

    You are comparing a study that involves chronic patients and a study that involves acute patients. What do you think will happen when Invivo starts the chronic trial? Invoivo's current study depends on some one healthy becoming paralyzed--not already paralyzed.

  • Reply to

    CTIX Uplisting?

    by bint244 Jul 21, 2015 7:48 AM
    seekingprofits247 seekingprofits247 Jul 25, 2015 12:05 PM Flag

    I got in ONVO about 3 months after they started trading. Once I realized that Pfizer wouldn't renew its contract with Organovo in May of 2013, I sold out even though ONVO was on a roll. I also figured United Therapeutics would do the same and it has. The question is why isn't big pharma buying into these ONVO's essays? Looking at revenues, they basically are no better than what they were when I sold out. But the main reason--printing a liver, etc is a decade or 2 away if ever. I've moved on to company's like HART (trachea, esophagus, heart valve, lung) and NVIV (spinal cord). Not saying they will work, but their first products, HART Trachea and NVIV spinal cord tissue, should be proven or disapproven within the next year 2 to 3 years.

  • seekingprofits247 seekingprofits247 Jul 25, 2015 11:37 AM Flag

    The study is on https://clinicaltrials.gov/ct2/show/NCT02339233?term=Harkema&rank=2. There isn't any commercial company associated with the study and the study won't be completed until jan 2020. Lastly, NVIV is well aware of this and states it wants to BE the SCI COMPANY. I would think they would license the technology if it adds value.

  • seekingprofits247 seekingprofits247 Jul 25, 2015 11:27 AM Flag

    According to the article some have gotten sexual function as well as B&B. This is good; however, my expectation is that scaffold+cells will exceed scaffold alone and that doctors will use the least invasive procedure to treat SCI patients. I'm not a seller because of this. For whatever reasons, the University of Louisville has been much more effective in getting its story out than NVIV. I've seen the story on CBS news sometime last year. UL is just better at messaging IMO. But that isn't as important as a potential product that will be going through a pivotal trial next year.

  • Reply to

    CTIX Uplisting?

    by bint244 Jul 21, 2015 7:48 AM
    seekingprofits247 seekingprofits247 Jul 22, 2015 12:45 PM Flag

    These developmental biotech companies trade on news. As news fades so does the price. The key is getting institutional investors invested in the company--which means uplisting. No ifs ands or buts. More of them involved more shares get "locked" up if news stays relatively positive.

  • Reply to

    CTIX Uplisting?

    by bint244 Jul 21, 2015 7:48 AM
    seekingprofits247 seekingprofits247 Jul 21, 2015 3:16 PM Flag

    I made a mistake. For BCLI and NVIV I included time for the reverse split. So knock a week off. :o)

  • Reply to

    CTIX Uplisting?

    by bint244 Jul 21, 2015 7:48 AM
    seekingprofits247 seekingprofits247 Jul 21, 2015 2:46 PM Flag

    I've been through this BCLI, NVIV, ONVO (don't buy it), and one or two others. It may take up to 4 weeks before we hear anything. But if they have all their ducks in row like BCLI and NVIV did, about 2 weeks. BCLI and NVIV did a reverse splits and were up on the NASDAQ Capital Markets in a about 2 weeks. I would think we should have the same result here.

  • Reply to

    Today is DAY 4...

    by gpls72 Jul 21, 2015 1:43 PM
    seekingprofits247 seekingprofits247 Jul 21, 2015 1:55 PM Flag

    Actually today is day 5! Just need to hold till 4.

  • Reply to

    CTIX Uplisting?

    by bint244 Jul 21, 2015 7:48 AM
    seekingprofits247 seekingprofits247 Jul 21, 2015 10:17 AM Flag

    July 8th - "Cellceutix last week learned that the application remains pending due to the price of CTIX stock currently below the minimum requirement."

    I believe they need to meet the minimum $3 closing price for 5 business days requirement for the Nasdaq Capital Market. But to qualify under that criteria, CTIX needs to have "net tangible assets of $5 million." From what I can tell they have the $5 mill and will have the 5th $3 closing by end of day. Net Tangible Assets is another way of saying Book Value. Reference Nasdaq's Initial Listing Guide. Yahoo! Finance has Book Value at $0.08 per share.

  • Reply to

    Curious

    by gahoagie Jul 16, 2015 1:17 PM
    seekingprofits247 seekingprofits247 Jul 17, 2015 12:43 PM Flag

    Longnviv, company said they believe it was unsafe to transport patients between hospitals.

  • Reply to

    Curious

    by gahoagie Jul 16, 2015 1:17 PM
    seekingprofits247 seekingprofits247 Jul 17, 2015 12:42 PM Flag

    fish56, Jordan wasn't enrolled until October 2014.

  • Reply to

    The way it's looking

    by lee122oneill Jul 17, 2015 12:13 PM
    seekingprofits247 seekingprofits247 Jul 17, 2015 12:40 PM Flag

    Can't wait for close on Tuesday above $3.

  • Reply to

    Kevetrin orphan drug status

    by georgejjl Jul 15, 2015 9:49 PM
    seekingprofits247 seekingprofits247 Jul 17, 2015 12:38 PM Flag

    And they couldn't have just got orphan status off of just 1 successful patient with ovarian cancer.

  • Incidence

    It is estimated that the annual incidence of SCI, not including those who die at the scene of the
    accident, is approximately 40 cases per million population in the U.S. or approximately 12,500 new
    cases each year, given the current population size of 313 million people in the U.S.

    Company presentation has 12,000

    Prevalence

    The number of people in the U.S. who are alive in 2014 who have SCI has been estimated to be
    approximately 276,000 persons, with a range from 240,000 to 337,000 persons.

    Company presentation has 273,000.

  • Incidence

    It is estimated that the annual incidence of SCI, not including those who die at the scene of the
    accident, is approximately 40 cases per million population in the U.S. or approximately 12,500 new
    cases each year, given the current population size of 313 million people in the U.S.

    Company presentation has 12,000

    Prevalence

    The number of people in the U.S. who are alive in 2014 who have SCI has been estimated to be
    approximately 276,000 persons, with a range from 240,000 to 337,000 persons.

    Company presentation has 273,000.

    Sentiment: Strong Buy

  • Incidence

    It is estimated that the annual incidence of SCI, not including those who die at the scene of the
    accident, is approximately 40 cases per million population in the U.S. or approximately 12,500 new
    cases each year, given the current population size of 313 million people in the U.S.

    Company presentation has 12,000

    Prevalence

    The number of people in the U.S. who are alive in 2014 who have SCI has been estimated to be
    approximately 276,000 persons, with a range from 240,000 to 337,000 persons.

    Company presentation has 273,000.

    Sentiment: Strong Buy

  • Reply to

    Curious

    by gahoagie Jul 16, 2015 1:17 PM
    seekingprofits247 seekingprofits247 Jul 17, 2015 11:18 AM Flag

    Thanks. An email just cost nothing but a little time. If I get an answer great. I was not expecting to get a call from Brian.

    Sentiment: Strong Buy

  • Reply to

    Curious

    by gahoagie Jul 16, 2015 1:17 PM
    seekingprofits247 seekingprofits247 Jul 17, 2015 10:57 AM Flag

    On August 29th, 2014 I wrote Mr. Perrin directly on this issue. He had Brian talk to me. With respect to the idea below of transporting a patient from a non-approved site to an approved site to speed up enrollment, Brian said that they discussed the idea internally in the past and determined that it would be unsafe for the patient.

    I went on to tell Mr. Perrin that that they needed to significantly increase the number of sites to at least 12 or possibly more because at that point in time we had no patient and the issue needed to be resolved by the end of 2014. I can't say they followed my advice, but at they reached the same conclusion.

    Sentiment: Strong Buy

  • Reply to

    Some dummy is either selling or shorting

    by mix.jack Jul 7, 2015 9:46 AM
    seekingprofits247 seekingprofits247 Jul 7, 2015 9:51 AM Flag

    or accumulating...

    Sentiment: Strong Buy